Ultrasound Quarterly – September 1, 2020
Abstract
The Society of Radiologists in Ultrasound convened a panel of specialists in contrast-enhanced ultrasound (CEUS) to produce a white paper on noncardiac CEUS in North America. The panel met in Chicago, Illinois, on October 24 and 25, 2017. The recommendations are based on analysis of current literature and common practice strategies and are thought to represent a reasonable approach to introduce the advantages of this safe and noninvasive technique for the benefit of our patients. Characterization of liver nodules, and pediatric vascular and intravesicular applications comprise the approved indications for CEUS in the United States. They, along with the very successful off-label use of CEUS for the kidney, are included in this publication.
Other off-label uses are presented with emphasis on their value and literature support in the online version.
Authors: Barr, Richard G. MD, PhD∗,†; Wilson, Stephanie R. MD‡; Lyshchik, Andrej MD, PhD§; McCarville, Beth MD∥; Darge, Kassa MD¶; Grant, Edward MD#; Robbin, Michelle MD∗∗; Wilmann, Juergen Karl MD††; Chong, Wui K. MD‡‡; Fleischer, Arthur MD§§; Paltiel, Harriet J. MD∥∥
∗Northeastern Ohio Medical University, Rootstown; †Southwoods Imaging, Youngstown, OH; ‡University of Calgary, Calgary, Alberta, Canada; §Thomas Jefferson University Hospital, Philadelphia, PA; ∥St Jude’s Children’s Hospital, Memphis, TN; ¶Children’s Hospital of Philadelphia, Philadelphia, PA; #University of Southern California, Los Angeles, CA; ∗∗University of Alabama, Birmingham, AL; ††Stanford University, Palo Alto, CA; ‡‡MD Anderson, Houston, TX; §§Vanderbilt University, Nashville, TN; ∥∥Department of Radiology, Boston Children’s Hospital, Boston, MA.
Volume 36 – Issue 3 – p 206-217
